

Fundamental dimension Equity attribute | CBDWPeer $0.00010.00% Cap $134.2KP/E -0.0x QuantScore29/100 | ASHILeader $0.01110.00% Cap $5.24KP/E -0.1x QuantScore38/100 | EQLBPeer $0.000.00% Cap $5.71KP/E -0.4x QuantScore34/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
28/100 |
51/100 |
45/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 20/100 | 23/100 |
Growth Revenue / earnings growth & margins | 33/100 | 14/100 | 69/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.1x | -0.4x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 1.2x | -148.8x | -4.3x |
Price / Sales | — | 0.0x | 0.2x |
Price / Free Cash Flow | -0.1x | -0.1x | -0.0x |
PEG ratio | -0.00 | 0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | -439.38 (Distress) | -0.92 (Distress) | -463.68 (Distress) |
Total debt / equity | -0.57 | -1.46 | -0.49 |
Quick ratio | 0.0x | 0.6x | 0.0x |
Interest coverage | -0.2x | -1.7x | -2.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -100.0% | +14.4% | +54.3% |
Net income growth YoY | +71.3% | -780.5% | -59.9% |
Gross margin (TTM) | 0.0% | -60.5% | 58.0% |
Operating margin (FY) | — | -71.8% | -523.4% |
FCF margin (FY) | — | -5.2% | -488.6% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | 0.0% | +0.0% |
3M return | -66.7% | 0.0% | -60.0% |
6M return | -83.3% | -74.5% | -60.0% |
Year to date | -85.7% | 0.0% | -60.0% |
1Y return | -87.5% | -43.1% | -97.5% |
3Y return | -99.5% | +1004.5% | -95.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0062 -6316.2% premium | $3.21 +28815.6% upside | $-0.0004 -1021.7% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |